
CAS Name: (1S,9S)-1-Amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-10H,13H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13-dionePercent Composition: C 66.20%, H 5.09%...
Literature References: Topoisomerase I inhibitor; synthetic analogue of camptothecin, q.v. Prepn: H. Terasawa et al., EP 495432 (1992 to Daiichi); of mesylate: S. Kamihara et al., EP 737686; eidem, US 6552197 (1996, 2003 both to Daiichi). HPLC determn in mouse plasma: T. Oguma et al., Biol. Pharm. Bull. 24, 176 (2001). Clinical pharmacokinetics and evaluation in advanced leukemia: F. J. Giles et al., Clin. Cancer Res. 8, 2134 (2002); in advanced solid malignancies: M. A. Garrison et al., ibid. 9, 2527 (2003); in breast cancer: F. J. Esteva et al., Cancer 98, 900 (2003); in gastric cancer: J. A. Ajani et al., Invest. New Drugs 23, 479 (2005).
CAS Name: (2E)-4-Hydroxy-2-nonenal
Additional Names: 4-HNE
Percent Composition: C 69.19%, H 10.32%, O 20.48%
Literature References: Toxic aldehyde formed during lipid peroxidation in response to oxidative stress. Reacts primarily with the amino acids His or Lys to form an adduct which may alter protein function. Increased levels of the HNE-adduct are seen in Alzheimer's disease and after ozone exposure. Identification of cytotoxic activity of lipid oxidative products: E. Schauenstein, H. Esterbauer, Monatsh. Chem. 94, 164 (1963). Prepn: H. Esterbauer, W. Weger, ibid. 98, 1994 (1967). Synthesis: H. W. Gardner et al., Lipids 27, 686 (1992). Quantitative analysis by uv, GC/MS, HPLC: M. Kinter in Free Radicals N. A. Punchard, F. J. Kelly, Eds. (IRL Press, Oxford, UK, 1996) pp 133-145. Cytotoxicity: A. Benedetti et al., Biochim. Biophys. Acta 620, 281 (1980). Structural definition of adduct sites: D. V. Nadkarni, L. M. Sayre, Chem. Res. Toxicol. 8, 284 (1995); by MS: M. S. Bolgar, S. J. Gaskell, Anal. Chem. 68, 2325 (1996). Ozone-induced formation: A. Kirichenko et al., Toxicol. Appl. Pharmacol. 141, 416 (1996). Role in Alzheimer's disease: R. J. Mark et al., J. Neurochem. 68, 255 (1997); L. M. Sayre et al., ibid. 2092.
CAS Name: (1aR,2aR,3S,6R,6aS,8aS,8bR,9R)-Hexahydro-2a-hydroxy-8b-methyl-9-(1-methylethenyl)-3,6-methano-8H-1,5,7-trioxacyclopenta[ij]cycloprop[a]azulene-4,8(3H)-dione
Percent Composition: C 61....
Literature References: Toxic component of picrotoxin, q.v. Prepn from picrotoxin: Horrmann, Ber. 45, 2090 (1912). Structure: Conroy, J. Am. Chem. Soc. 73, 1889 (1951); 79, 5550 (1957); Craven, Tetrahedron Lett. no. 19, 21 (1960). Total synthesis: E. J. Corey, H. L. Pearce, J. Am. Chem. Soc. 101, 5841 (1979). Structure-activity relationship: C. H. Jarboe et al., J. Med. Chem. 11, 729 (1968). Review: Porter, Chem. Rev. 67, 441 (1967).
CAS Name: (1R)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido-[1,2-a][1,5]diazocin-8-one
Additional Names: baptitoxine; sophorine; ulexine
Trademarks: Cytiton (USSR)
Percent Composition: C 6...
Literature References: Toxic principle in seed of Laburnum anagyroides Medik. and other Leguminosae. Extraction: Ing, J. Chem. Soc. 1931, 2200; Späth, Galinovsky, Ber. 65, 1526 (1932); 66, 1338 (1933); Lecoq, Bull. Soc. Chim. Fr. 10, 153 (1943). Structure: Ing, J. Chem. Soc. 1932, 2778. Synthesis: Bohlmann et al., Angew. Chem. 67, 708 (1955); Van Tamelen, Baran, J. Am. Chem. Soc. 77, 4944 (1955). Absolute configuration: Okuda et al., Chem. Ind. (London) 1961, 1751. Pharmacological properties: R. B. Barlow, L. J. McLeod, Br. J. Pharmacol. 35, 161 (1969).
CAS Name: (2b,4a,15a)-15-Hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-b-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic acid dipotassium salt
Additional Names: potassium atractylate; atra...
Literature References: Toxic principle isolated from the thistle Atractylis gummifera L., Compositae: M. Lefranc, Compt. Rend. 67, 954 (1868). Structure and stereochemistry of the aglycone, atractyligenin: F. Piozzi et al., Tetrahedron Suppl. 8 II, 515 (1966); total synthesis of (±)-form: A. K. Singh et al., J. Am. Chem. Soc. 109, 6187 (1987). Structure and stereochemistry of atractyloside: eidem, Gazz. Chim. Ital. 97, 935 (1967). Toxicity studies: G. Cascio et al., Boll. Soc. Ital. Biol. Sper. 44, 253 (1968). Review: Atractyloside: Chemistry, Biochemistry, and Toxicology, R. Santi, S. Luciani, Eds. (Piccin Medical Books, Padova, Italy, 1978) 136 pp.
CAS Name: (1a)-1,2-Dihydro-12-hydroxysenecionan-11,16-dione
Additional Names: platifillin
Percent Composition: C 64.07%, H 8.07%, N 4.15%, O 23.71%
Literature References: Toxic pyrrolizidine alkaloid from Senecio platyphyllus DC. and other Senecio spp., Compositae: Orékhov, Tiedebel, Ber. 68, 650 (1935); Orékhov et al., ibid. 1886; Konovalova, Orékhov, ibid. 69, 1908 (1936); Bull. Soc. Chim. Fr. [5] 4, 2037 (1937); Allen, Am. J. Pharm. 117, 110 (1945). Structure: Dry et al., J. Chem. Soc. 1955, 63. Comprehensive reviews of platyphylline and other pyrrolizidine alkaloids: L. Bull et al., The Pyrrolizidine Alkaloids (North-Holland, Amsterdam, 1968) 293 pp; F. L. Warren in The Alkaloids vol. 12, R. H. F. Manske, Ed. (Academic Press, New York, 1970) pp 245-331.
CAS Name: (13a,14a)-14,19-Dihydro-12,13-dihydroxy-20-norcrotolanan-11,15-dione
Additional Names: crotaline; MCTPercent Composition: C 59.06%, H 7.13%, N 4.30%, O 29.50%
Literature References: Toxic pyrrolizidine alkaloid isolated from Crotalaria spp. Isoln: R. Adams, E. F. Rogers, J. Am. Chem. Soc. 61, 2815 (1939); R. B. Tinker, W. M. Lauter, Econ. Bot. 10, 254 (1956); C. C. J. Culvenor, L. W. Smith, Aust. J. Chem. 16, 239 (1963). Structure: R. Adams et al., J. Am. Chem. Soc. 74, 5612 (1952). Stereochemistry: D. J. Robins, D. H. G. Crout, J. Chem. Soc. C 1969, 1386. Crystal structure: H. Stoeckli-Evans, Acta Crystallogr. B35, 231 (1979). Stereoselective synthesis: H. Niwa et al., Tetrahedron 48, 10531 (1992). ELISA measurment: M. A. Bober et al., Toxicon 27, 1059 (1989). Toxicology: P. M. Newberne et al., Toxicol. Appl. Pharmacol. 18, 387 (1971); R. A. Roth et al., ibid. 60, 193 (1981). Review of carcinogenicity studies: IARC Monographs 10, 291-302, 333-342 (1976). Comprehensive reviews: L. Bull et al., The Pyrrolizidine Alkaloids (North-Holland, Amsterdam, 1968) 293 pp; D. J. Robins, Fortschr. Chem. Org. Naturst. 41, 115-203 (1982). Review of pulmonary toxicity: D. W. Wilson et al., Crit. Rev. Toxicol. 22, 307-325 (1992).
Additional Names: Pentalin
Percent Composition: C 11.87%, H 0.50%, Cl 87.63%
Literature References: Toxicity data: G. S. Barsoum, K. Saad, Q. J. Pharm. Pharmacol. 7, 205 (1934).
CAS Name: 1,1'-Oxybis(2-ethoxy)ethane
Additional Names: diethylene glycol diethyl ether
Percent Composition: C 59.23%, H 11.18%, O 29.59%
Literature References: Toxicity data: H. F. Smyth et al., J. Ind. Hyg. Toxicol. 23, 259 (1941).
CAS Name: 2-Methoxyethanol acetate
Additional Names: ethylene glycol monomethyl ether acetate
Percent Composition: C 50.84%, H 8.53%, O 40.63%
Literature References: Toxicity data: H. F. Smyth et al., J. Ind. Hyg. Toxicol. 23, 259 (1941). Series of articles on toxicology: Environ. Health Perspect. 57, 1-275 (1984).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
